Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)
China
· Delayed Price · Currency is CNY 6.58
-0.73 (-9.99%)
Apr 29, 2026, 3:04 PM CST
SHE:002099 Revenue
Zhejiang Hisoar Pharmaceutical had revenue of 486.50M CNY in the quarter ending March 31, 2026, with 0.01% growth. This brings the company's revenue in the last twelve months to 1.86B, down -1.88% year-over-year. In the year 2025, Zhejiang Hisoar Pharmaceutical had annual revenue of 1.86B, down -4.01%.
Revenue (ttm)
1.86B
Revenue Growth
-1.88%
P/S Ratio
5.60
Revenue / Employee
712.66K
Employees
2,611
Market Cap
10.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.86B | -77.77M | -4.01% |
| Dec 31, 2024 | 1.94B | -233.42M | -10.75% |
| Dec 31, 2023 | 2.17B | -532.26M | -19.68% |
| Jan 1, 2023 | 2.70B | 219.32M | 8.83% |
| Jan 1, 2022 | 2.48B | 13.44M | 0.54% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Porton Pharma Solutions | 3.50B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| Mayinglong Pharmaceutical Group | 3.91B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Yantai Dongcheng Pharmaceutical Group | 2.68B |
| Shanghai Yizhong Pharmaceutical | 325.20M |
| Guangdong Taienkang Pharmaceutical | 674.49M |
| Ningbo Menovo Pharmaceutical | 1.56B |